Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOEX.L Regulatory News (OEX)

  • There is currently no data for OEX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Securities and Cleansing Notice

22 Mar 2022 07:00

RNS Number : 5742F
Oilex Ltd
22 March 2022
 

ASX - RNS Announcement

22 March 2022

 

ASX: OEX

AIM: OEX

 

 

ISSUE OF SECURITIES AND CLEANSING NOTICE

 

(Oilex or the Company) wishes to advise that following shareholder approval received at the 17 February 2022 Shareholder Meeting, it has issued the following securities:

 

· 711,295,152 unquoted options (Placement Options). The Placement Options are exercisable at GBP 0.28 pence (0.518 AUD cents) per share on or before 31 December 2022. The Options were issued to shareholders as a one free attaching unquoted option for every two Placement Shares subscribed for, in the January 2022 placement,

 

· 54,839,185 unquoted options, exercisable at GBP 0.14 pence (0.259 AUD cents) on or before 31 December 2023 (Fee Options), to Novum Securities.

 

Exercise of Options

Novum has now exercised the 54,839,185 unquoted Fee Options into fully paid ordinary shares.

 

AIM Admission and Total Voting Rights

 

Application has been made to the London Stock Exchange plc for the admission of 54,839,185 Shares to trade on AIM (Admission). Admission of the Shares is expected to become effective and dealings to commence at 8.00 a.m. on 24 March 2022. Following Admission, the Company will have 7,167,790,704 shares in issue. The Company does not currently hold any shares in treasury. Accordingly, the total number of voting rights will be 7,167,790,704.

 

Section 708A(5)(e) Statement

 

The Corporations Act (Cth) (Act) restricts the on-sale of securities issued without disclosure, unless the sale is exempt under section 708 or 708A of the Act. By giving this notice, the on sale of the Shares noted above will fall within the exemption in section 708A(5) of the Act.

 

Pursuant to the issue of the 54,839,185 Ordinary Shares on 17 March 2022, Oilex gives notice under section 708A(5)(e) of the Act that:

 

1) Oilex issued the Shares without disclosure to investors under Part 6D.2 of the Act;

 

2) As at the date of this notice, Oilex has complied with:

a) the provisions of Chapter 2M of the Act as they apply to Oilex; and

b) section 674 of the Act; and

 

3) As at the date of this notice, there is no information:

(i) That has been excluded from a continuous disclosure notice in accordance with the ASX Listing Rules; and

(ii) That investors and their professional advisers would reasonably require for the purpose of making an informed assessment of:

A. The assets and liabilities, financial position and performance, profits and losses and prospects of the Company; or

B. The rights and liabilities attaching to the Shares.

 

The relevant Appendix 2A is lodged via ASX on-line forms.

 

For and on behalf of Oilex Ltd

Suzie Foreman

Company Secretary

 

 

 

For further information, please contact:

 

Investor Enquires

Oilex Ltd

Roland Wessel

Chief Executive Officer

Email: oilex@oilex.com.au

Tel: +61 8 9485 3200

Australia

AIM Broker

Novum Securities

Broker

Colin Rowbury

Email: crowbury@novumsecurities.com

Tel: +44 20 7399 9427

UK

AIM Nominated Adviser

Strand Hanson Limited

Nominated Adviser

Rory Murphy/Ritchie Balmer

Email: oilex@strandhanson.co.uk

Tel: +44 20 7409 3494

UK

Media Enquires (UK)

Vigo Communications

Public Relations

Patrick d'Ancona/Chris McMahon

Email: patrick.dancona@vigocomms.com

chris.mcmahon@vigocomms.com

Tel:+ 44 20 7390 0230

UK

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEJTMFTMTJTMFT
Date   Source Headline
24th Aug 20177:00 amRNSCore Analysis and Review Confirms Cambay Potential
7th Aug 20177:00 amRNSExpiry of Unlisted Options
31st Jul 20177:49 amRNSSecurities Trading Policy
31st Jul 20177:00 amRNSQuarterly Report 30 June 2017
19th Jun 20177:00 amRNSPartial Receipt of Outstanding Cash Calls
19th Jun 20177:00 amRNSTrading Halt
6th Jun 20177:10 amRNSCambay PSC Workover and Project Update
30th May 20177:59 amRNSAppendix 3X P Haywood
30th May 20177:47 amRNSOilex Appoints New UK Based Non-Executive Director
23rd May 20177:00 amRNSCambay Production Update - C-73 and C-77
22nd May 20179:31 amRNSTranche 2 Unlisted Options Issued
12th May 201710:10 amRNSBhandut and Cambay Updates
10th May 20179:57 amRNSAppendix 3B Issue of Shares & Section 708 Notice
3rd May 20177:00 amRNSResults of 3 May 2017 General Meeting
28th Apr 20179:31 amRNSQuarterly Report 31 March 2017
28th Apr 20179:20 amRNSMobilisation of Workover Rig at Cambay
21st Apr 20178:19 amRNSChange of ASX Share Registry Address
21st Apr 20177:00 amRNSAward of Key Contracts Cambay-23z Core Analysis
18th Apr 20177:00 amRNSNotice of Change of Substantial Interest
6th Apr 20177:00 amRNSNotice of Change of Substantial Interest
4th Apr 20178:28 amRNSOilex Engagement via Vox Markets
3rd Apr 20177:00 amRNSNotice of General Meeting
31st Mar 20179:16 amRNSAppendix 3B Issue of Shares and Section 708 Notice
31st Mar 20177:00 amRNSOilex Investor Presentation April 2017
24th Mar 20177:00 amRNSAppendix 3B Issue of Shares and Section 708 Notice
17th Mar 20177:08 amRNSAppendix 3B
17th Mar 20177:00 amRNSAppendix 3Y J Salomon
17th Mar 20177:00 amRNSManaging Director - Contract Extension
16th Mar 20177:00 amRNSInterim Report 31 December 2016
16th Mar 20177:00 amRNSReinstatement to Official Quotation
15th Mar 201710:09 amRNSPlacement to Fund Cambay Work Programme
15th Mar 20177:00 amRNSSuspension of Trading on ASX
13th Mar 20177:00 amRNSTrading Halt
1st Mar 20177:00 amRNSCancellation of Unlisted Options
23rd Feb 20177:57 amRNSOilex Appoints New Chairman
13th Feb 20177:00 amRNSCancellation of Unlisted Options
30th Jan 20179:18 amRNSQuarterly Report 31 December 2016
30th Jan 20179:09 amRNSOilex Investor Presentation Jan Feb 2017
4th Jan 20177:00 amRNSCancellation of Unlisted Options
19th Dec 20167:00 amRNSAppendix 3B - Issue of Retention Rights
19th Dec 20167:00 amRNSAppendix 3Y J Salomon
13th Dec 20168:23 amRNSOilex tenders for 55% interest in Cambay PSC
6th Dec 20167:00 amRNSExpiry of Unlisted Options
24th Nov 20167:00 amRNSAppendix 3Y J Salomon
24th Nov 20167:00 amRNSAppendix 3B
23rd Nov 20167:00 amRNSResults of Annual General Meeting 23 November 2016
23rd Nov 20167:00 amRNSWaiver of ASX Listing Rule 10.13.5
23rd Nov 20167:00 amRNSChairman's Address to Shareholders
14th Nov 20167:00 amRNSExpiry of Unlisted Options
7th Nov 20167:00 amRNSExpiry of Unlisted Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.